Inventurus Knowledge Solutions shares tank over 12% as its lock-in period ends; check details

Inventurus Knowledge Solutions (IKS) shares tumble over 12% on Monday, March 17, as the three-month lock-in period for the company ended.

Its market capitalisation stood at ₹24,842.08 crore.

Over a month’s period, the scrip has tanked over 16%, while year-to-date, shares of the firm have lost over 26%. In the last five trading sessions, IKS shares have declined almost 14%.

Shares of IKS were one of the most highly traded stocks on Monday. Counter of Inventurus Knowledge Solutions saw 9.94 times higher volume than the daily average.

Backed by Rekha Jhunjhunwala and RARE Enterprises, Inventurus Knowledge Solutions was listed on the stock exchanges on December 19, 2024.

The initial share sale of IKS received a robust response during the bidding period. The ₹2,497.92 crore Inventurus Knowledge Solutions IPO was subscribed 52.68 times, as the qualified institutional buyers (QIBs) portion was booked 80.64 times, the non-institutional investors part was subscribed 23.25 times, and the retail quota was subscribed 14.56 times.

The public offer was exclusively an offer-for-sale (OFS) of 1.88 crore shares without any fresh issue component.

Inventurus Knowledge Solutions is a technology-enabled healthcare solutions provider. It was founded in 2006 with the goal of addressing the financial, clinical and operational needs of the United States-based healthcare organisations.

Currently, it offers a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a prime focus on the US markets.

The company is a partner for outpatient and inpatient care organisations, enabling healthcare organisations to deliver superior clinical care and to improve population health outcomes. The company also helps its clients in the transition to the ‘fee for value’ model while optimising their revenue and reducing operating costs.